ATE491447T1 - Flavonoide und tocotrienole enthaltende zusammensetzungen und deren verwendungen - Google Patents

Flavonoide und tocotrienole enthaltende zusammensetzungen und deren verwendungen

Info

Publication number
ATE491447T1
ATE491447T1 AT05743969T AT05743969T ATE491447T1 AT E491447 T1 ATE491447 T1 AT E491447T1 AT 05743969 T AT05743969 T AT 05743969T AT 05743969 T AT05743969 T AT 05743969T AT E491447 T1 ATE491447 T1 AT E491447T1
Authority
AT
Austria
Prior art keywords
tocotrienols
compositions containing
containing flavonoids
flavonoids
disclosed
Prior art date
Application number
AT05743969T
Other languages
English (en)
Inventor
Najla Guthrie
Original Assignee
Kgk Synergize Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kgk Synergize Inc filed Critical Kgk Synergize Inc
Application granted granted Critical
Publication of ATE491447T1 publication Critical patent/ATE491447T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
AT05743969T 2004-05-26 2005-05-24 Flavonoide und tocotrienole enthaltende zusammensetzungen und deren verwendungen ATE491447T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57449004P 2004-05-26 2004-05-26
PCT/IB2005/001427 WO2005115378A1 (en) 2004-05-26 2005-05-24 Compositions comprising flavonoids and tocotrienols and methods thereof

Publications (1)

Publication Number Publication Date
ATE491447T1 true ATE491447T1 (de) 2011-01-15

Family

ID=35450644

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05743969T ATE491447T1 (de) 2004-05-26 2005-05-24 Flavonoide und tocotrienole enthaltende zusammensetzungen und deren verwendungen

Country Status (11)

Country Link
US (2) US20060013901A1 (de)
EP (1) EP1748774B1 (de)
KR (1) KR20070088325A (de)
CN (1) CN101001624A (de)
AT (1) ATE491447T1 (de)
AU (1) AU2005247162A1 (de)
CA (1) CA2567969A1 (de)
DE (1) DE602005025339D1 (de)
IL (1) IL179544A0 (de)
WO (1) WO2005115378A1 (de)
ZA (1) ZA200610168B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA200610170B (en) * 2004-05-26 2008-06-25 Kgk Synergize Inc Pharmaceutical products for treating neoplastic disease and inflammation
CA2567963A1 (en) * 2004-05-26 2005-12-08 Kgk Synergize Inc. Functional foods comprising flavonoids and tocotrienols and methods thereof
US20080166418A1 (en) * 2007-01-04 2008-07-10 Sones Scott F Krill oil compositions
JP2008247826A (ja) * 2007-03-30 2008-10-16 Hiroshima Univ 血糖値調整剤およびまたは血中コレステロール値調整剤
EP2170331B1 (de) * 2007-06-29 2014-12-03 Laboratoires Dr Ng Payot Synergistische kombination von proanthoyanidinen, gamma-tocotrienol und niacin
JP5735184B2 (ja) * 2012-10-12 2015-06-17 国立大学法人 琉球大学 柑橘類由来のノビレチン及びタンゲレチン含有物の製造方法及びその方法で得られたノビレチン及びタンゲレチン含有物
DK2919777T3 (da) * 2012-11-13 2020-03-09 Invictus Biotechnology Pty Ltd Transmukosal afgivelse af tocotrienol
US9132117B2 (en) 2013-06-17 2015-09-15 Kgk Synergize, Inc Compositions and methods for glycemic control of subjects with impaired fasting glucose

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4603142A (en) * 1984-06-01 1986-07-29 Wisconsin Alumni Research Foundation Cholesterol lowering method of use
US5217992A (en) * 1989-10-04 1993-06-08 Bristol-Myers Squibb Company Tocotrienols in the treatment of hypercholesterolemia, hyperlipidemia and thromboembolic disorders
PL335506A1 (en) * 1997-03-04 2000-04-25 Wisconsin Alumni Res Found Method of inhibiting neoplasm growth by means of combinations of isoprenoids and statins
US20010055627A1 (en) * 1997-09-26 2001-12-27 Najla Guthrie Compositions And Methods For Regulating Lipoproteins And Hypercholesterolemia With Limonoids, Flavonoids And Tocotrienols
US6251400B1 (en) * 1997-09-26 2001-06-26 Kgk Synergize Inc Compositions and methods of treatment of neoplastic diseases and hypercholesterolemia with citrus limonoids and flavonoids and tocotrienols
US6239114B1 (en) * 1997-09-26 2001-05-29 Kgk Synergize Compositions and methods for treatment of neoplastic diseases with combinations of limonoids, flavonoids and tocotrienols
KR20000019716A (ko) * 1998-09-15 2000-04-15 박호군 바이오플라보노이드 화합물을 포함하는 혈당 강하용 조성물
US6987125B1 (en) * 1998-10-06 2006-01-17 The United States Of America As Represented By The Secretary Of Agriculture Compositions and methods of treating, reducing and preventing cardiovascular diseases and disorders with polymethoxyflavones
US6641847B1 (en) * 1999-06-01 2003-11-04 Ocean Spray Cranberries, Inc. Cranberry seed oil extract and compositions containing components thereof
US20020006953A1 (en) * 1999-11-05 2002-01-17 Carla R. McGill Modification of cholesterol concentrations with citus phytochemicals
CA2403548A1 (en) * 2000-03-17 2001-09-27 United States Department Of Agriculture Compositions and methods of treating, reducing, and preventing cardiovascular diseases and disorders with polymethoxyflavones
AU2001251610A1 (en) * 2000-04-13 2001-11-07 Ocean Spray Cranberries, Inc. Novel compositions derived from cranberry and grapefruit and therapeutic uses therefor
US6579544B1 (en) * 2000-05-31 2003-06-17 Nutriex, L.L.C. Method for supplementing the diet
WO2002022145A2 (en) * 2000-09-15 2002-03-21 Kgk Synergize Components of canola for the treatment of cancer
AU2001290166A1 (en) * 2000-09-15 2002-03-26 Kgk Synergize Components of canola for treating hyperlipidemia
GB0026018D0 (en) * 2000-10-24 2000-12-13 Novartis Nutrition Ag New composition
AU2001232182A1 (en) * 2001-01-15 2002-07-24 Kgk Synergize Compositions and methods for regulating lipoproteins and hypercholesterolmia with limonoids flavonoids and tocotrienols
AU2002308324B2 (en) * 2001-05-02 2008-04-03 Kgk Synergize Inc. Polymethoxylated flavones for treating insulin resistance
US7074825B2 (en) * 2002-03-07 2006-07-11 Huanbiao Mo Composition and method for treating cancer
EP1415549A1 (de) * 2002-11-01 2004-05-06 Galileo Laboratories, Inc. Synergistische Antioxidantien-Kombination aus Tocolen und Polyphenolen
US20050227930A1 (en) * 2004-04-08 2005-10-13 Kgk Synergize Inc. Cholesterol lowering combination
ZA200610170B (en) * 2004-05-26 2008-06-25 Kgk Synergize Inc Pharmaceutical products for treating neoplastic disease and inflammation

Also Published As

Publication number Publication date
DE602005025339D1 (de) 2011-01-27
AU2005247162A1 (en) 2005-12-08
WO2005115378A1 (en) 2005-12-08
WO2005115378B1 (en) 2006-02-16
IL179544A0 (en) 2007-07-04
CA2567969A1 (en) 2005-12-08
US20060013901A1 (en) 2006-01-19
CN101001624A (zh) 2007-07-18
ZA200610168B (en) 2008-06-25
EP1748774A4 (de) 2007-12-19
EP1748774A1 (de) 2007-02-07
US20090156665A1 (en) 2009-06-18
KR20070088325A (ko) 2007-08-29
EP1748774B1 (de) 2010-12-15

Similar Documents

Publication Publication Date Title
GEP20063806B (en) Pharmaceutical compositions of orally active taxane derivatives having enhanced bioavailability
BR0107869A (pt) Composições farmacêuticas eletrogiradas
BR0108435A (pt) Formulação e uso de entecavir de baixa dose
NO20062504L (no) Sammensetninger og doseringsformer for forbedret absorpsjon
AR033367A1 (es) Derivados de imidazopirimidina y derivados de triazolopirimidina, un procedimiento para su preparacion, medicamentos, una composicion farmaceutica, y uso de dichos derivados para la preparacion de medicamentos
AU2003247616A1 (en) Use of topical pharmaceutical compositions comprising an active agent and permeation-enhancing base for the manufacture of a medicament to treat various forms of inflammatory dermatosis
IL164699A (en) Derivatives of diketohydrazine compounds and pharmaceutical compositions and medicaments containing the compounds as the active ingredient
WO2005046640A3 (en) Multi-site drug delivery platform
BR0108584A (pt) Formulações contendo um fármaco anticolinérgico para o tratamento da broncopneumopatia crÈnica obtrutiva
DE60120648D1 (de) Formulierungen von copolymer 1 (glatirameracetat) zur oralen, nasalen und pulmonalen verabreichung
SG157406A1 (en) Oral medicament for the modified release of at least one active principle, in multi-microcapsule form
ATE331537T1 (de) Topisch anwendbare arzneimittelformulierung
SE0102036D0 (sv) Pharmaceutical formulation for the efficient administration of apomorphine, 6aR- (-) -N- Propyl- norapomorphine and their derivatives and pro-drugs thereof
BR0209283A (pt) Método para a fabricação de uma composição farmacêutica de baixa dosagem tendo distribuição e potência de droga uniforme
MX2007015480A (es) Formulaciones de dosificacion solida de medicamentos narcoticos que tienen adsorcion bucal mejorada.
ATE302746T1 (de) Amorphe salpetersäureester und deren pharmazeutische zusammensetzungen
ATE324886T1 (de) Feste arzneizusammensetzung enthaltend 4'-cyano- trifluoro-3-(4-fluorophenylsulphonyl) -2-hydroxy- 2-methylpropiono- m toluidide und pvp
WO2007022090A3 (en) Topical delivery with a carrier fluid
BR0214497A (pt) Composição farmacêutica que compreende um agonista do receptor 5ht1
ATE491447T1 (de) Flavonoide und tocotrienole enthaltende zusammensetzungen und deren verwendungen
TW200603787A (en) Topical preparations containing ambroxol
WO2002011694A3 (en) Compositions and dosage forms for application in the oral cavity in the treatment of mykoses
BRPI0412364A (pt) composição farmacêutica sólida, compreendendo amisulpride
WO2008062475A3 (en) Pharmaceutical compositions of ursodiol
BR0206960A (pt) Composição farmacêutica oral, e, uso de um polìmero de ftalato de hidroxipropilmetilcelulose

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties